Treatment of the Biceps With Concomitant Supraspinatus Tears
1 other identifier
interventional
180
3 countries
4
Brief Summary
The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2021
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 4, 2022
CompletedFirst Posted
Study publicly available on registry
December 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
April 25, 2025
April 1, 2025
5 years
December 4, 2022
April 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ASES score
American Shoulder and Elbow Surgeon (ASES) score. From 0 (worst) to 100 (best).
At 24 post-operative months
Secondary Outcomes (16)
VAS pain
At 24 post-operative months
SSV
At 24 post-operative months
LHB score
At 24 post-operative months
AFF
At 24 post-operative months
ER at side
At 24 post-operative months
- +11 more secondary outcomes
Study Arms (3)
Leaving LHB Intact
NO INTERVENTIONThe long head of the biceps (LHB) will be left intact.
LHB tenotomy
EXPERIMENTALThe long head of the biceps (LHB) will be cut at its origin.
LHB Tenodesis
EXPERIMENTALThe long head of the biceps (LHB) will be cut at its origin and reattached.
Interventions
Will be performed arthroscopically by cutting the LHB at its origin with arthroscopic scissors
"ill be performed arthroscopically with a tenodesis at the top of the articular margin using an onlay technique.
Eligibility Criteria
You may qualify if:
- Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy.
- Full thickness tear of the supraspinatus tendon
- Intact subscapularis tendon
- Primary rotator cuff repair
- Age 50-80
You may not qualify if:
- Previous full thickness biceps tear
- Infection and neuropathic joints
- Known or suspected non-compliance, drug or alcohol abuse
- Patients incapable of judgement or under tutelage
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, contraindication for MRI scan etc.
- Enrolment of the investigator, his/her family members, employees and other dependent persons
- Patient declines to participate in study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- La Tour Hospitallead
Study Sites (4)
Sports Medicine and Shoulder Surgery, University of Michigan
Ann Arbor, Michigan, 48109, United States
Oregon Health & Science University
Portland, Oregon, 97239, United States
Group 23 Sports Medicine
Calgary, Alberta, T3B 6B7, Canada
la Tour hospital
Meyrin, Canton of Geneva, 1217, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Lädermann, MD
La Tour Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopaedic Surgeon FMH, Shoulder and Elbow Surgery Traumatology
Study Record Dates
First Submitted
December 4, 2022
First Posted
December 21, 2022
Study Start
June 1, 2021
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
April 25, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share